Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Plasmodium falciparum protein kinase 6 and hemozoin formation are inhibited by a type II human kinase inhibitor exhibiting antimalarial activity

Cell chemical biology(2025)10.1016/j.chembiol.2025.06.003Source: DataRank Database

Plasmodium falciparum protein kinase 6 and hemozoin formation are inhibited by a type II human kinase inhibitor exhibiting antimalarial activity is a research paper published in Cell chemical biology (2025). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)Impact (FWCI 9.17)OA: greenTopics (47)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (37)

Tiantian Jiang ORCID,Lushun Wang ORCID,Monica J. Bohmer ORCID,Subhoja Chakraborty,John Okombo ORCID

Live enrichment

PubMed:40628257 OpenAlex:https://openalex.org/W4412071073

University of Georgia

Grant: R01AI169892

University of Georgia

Grant: R01AI152533

National Institutes of Health National Institute of Allergy and Infectious Diseases

Grant: AI172066

National Institutes of Health

Grant: R37 AI050234

National Institutes of Health

Grant: R01 AI109023

National Institutes of Health

Grant: R01 AI185559

Bill and Melinda Gates Foundation

Grant: INV-039628

Bill and Melinda Gates Foundation

Grant: INV-045096

Bill and Melinda Gates Foundation

Grant: INV-033538

Bill and Melinda Gates Foundation

Grant: 1 S10OD028697-01

NIAID NIH HHS

Grant: R01 AI172066

NIH HHS

Grant: S10 OD028697

FWCI

9.17

Citation Percentile

1.0%

Citation Trend

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12406260/

publisherhttps://api.elsevier.com/content/article/PII:S2451945625001989?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2451945625001989?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.chembiol.2025.06.003

Fields of Study

Malaria Research and ControlMosquito-borne diseases and controlComputational Drug Discovery MethodsAntimalarialsHemeproteinsHumansProtein Kinase InhibitorsAnimalsMicePlasmodium falciparumProtozoan ProteinsMalariaPlasmodium bergheiStructure-Activity RelationshipBenzimidazoles

MeSH Terms

AnimalsAntimalarialsBenzimidazolesHemeproteinsHumansMalariaPlasmodium bergheiPlasmodium falciparumStructure-Activity RelationshipProtozoan ProteinsProtein Kinase InhibitorsMice

Keywords

HemozoinPlasmodium falciparumProtein kinase AKinasePharmacologyPlasmodium bergheiBiologyBiochemistryIn vivoHemeChemistryEnzymeMalariaPlasmodiumPfcrtHemozoin FormationType-Ii Kinase InhibitorP. Falciparum Chloroquine Resistance TransporterP. Falciparum Protein Kinase 6Pfpk6

Sustainable Development Goals

SDG 0: Good health and well-being